Bruce Cozadd

10 results

Bruce Cozadd, chief executive and chairman of Jazz Pharmaceuticals, which saw its shares fall more than 6 per cent overnight as it lowered full-year guidance. Photograph: Dara Mac Dónaill

Shares in Irish orphan drug group Jazz Pharmaceuticals fell more than 6 per cent per cent overnight as it lowered earnings guidance for the full year.(...)

Jazz Pharmaceuticals chief executive Bruce Cozadd: “We fully intend to have strong acquisitions going forward.” Photograph: Dara Mac Dónaill

Dublin-headquartered Jazz Pharmaceuticals intends to increase its headcount in Ireland by 10 per cent as it brings to market new drugs to deal with na(...)

“Thus far, 2017 has been a highly productive year,” said Bruce Cozadd, chairman and chief executive of Jazz Pharmaceuticals. Photograph: Dara Mac Donaill/The Irish Times

Dublin-headquartered Jazz pharmaceuticals has affirmed its full year guidance despite an adjusted net income drop in the second quarter of 5 per cent (...)

Jazz Pharmaceuticals chief executive Bruce Cozadd said the company delivered “solid growth”. Photograph: Dara Mac Donaill

Total revenues at Irish-headquartered Jazz Pharmaceuticals increased 12 per cent in 2016 to $1.5 billion (€1.42 billion ), while net income rose 14 pe(...)

 Bruce Cozadd, chief executive of Jazz Pharmaceuticals: ‘The remarkable pro-business environment in Ireland facilitates investments like this one.’ Photograph: Dara Mac Dónaill / The Irish Times

Jazz Pharma has officially opened a €50 million manufacturing plant near Athlone. Work on the Athlone facility began in February 2014 but it has now(...)

Bruce Cozadd, chief executive of Jazz Pharmaceuticals. Photograph: Dara Mac Dónaill / The Irish Times

Dublin-based Jazz Pharmaceuticals said revenues rose 15 per cent in the second quarter of the year as sales of its Xyrem product increased. The compa(...)

Jazz Pharmaceuticals CEO and chairman Bruce Cozadd, with Taoiseach Enda Kenny. Photograph:  Shane O’Neill / Fennells.

Shares in Jazz Pharma dropped over 7 per cent yesterday in US trade as the market digested results that came in slightly below expectations for(...)

An Taoiseach Enda Kenny and Bruce Cozadd, chairman and chief executive of Jazz Pharmaceuticals plc, in  Monksland, Athlone, Co Roscommon, on Monday.

Jazz Pharmaceuticals is investing €50 million on a new manufacturing plant outside Athlone, Co Roscommon, that will create 50 high-skilled full-time j(...)

Jazz Pharmaceuticals, the Dublin-based maker of the narcolepsy treatment Xyrem, is buying Italian rare disease drug developer Gentium in a $1 billion (...)

Investors in pharmaceuticals businesses are a nervous bunch as Bruce Cozadd and his team at Dublin-based Jazz Pharmaceuticals discovered this w(...)